You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Selective inhibitors of Heme Transporters as Antiparasitic Agents
SBC: RAKTA THERAPEUTICS INC Topic: NIAIDDESCRIPTION provided by applicant Neglected Tropical Diseases NTD which include helminthiasis and leishmaniasis are a group of thirteen parasitic and bacterial infections that affect over billion people Although these are devastating diseases of global concern their neglected status relative to other health concerns has resulted in a limited arsenal of therapeutic compounds for their ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Integrated biochemical and bioinformatic technologies for accurate transcriptome-wide full-length RNA assembly.
SBC: LUCIGEN CORPORATION Topic: 172DESCRIPTION provided by applicant The human transcriptome is significantly more complex than its cognate genome due to the hundreds of thousands of possible isoforms allele specific expression issues variable RNA editing changes and differential expression patterns spanning cell types developmental stages and physiological stresses Next generation sequencing NGS platforms are fundame ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Axonal Transport HTS Platform for Neurodegeneration Drug Discovery
SBC: Bellbrook Labs, LLC Topic: 106DESCRIPTION provided by applicant Neurodegenerative diseases that affect motor neurons such as PD ALS and HD represent an enormous unmet medical need that is growing with the aging population Existing treatments have little or no effect on the course of disease and patients have to cope with the loss of brain and body function for the rest of their lives Defects in the transport of organell ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Development of a novel highly effective influenza vaccine
SBC: FLUGEN INC Topic: NIAIDDESCRIPTION provided by applicant Seasonal influenza flu virus an NIAID category C priority pathogen causes widespread infection resulting in at least million cases of severe illness and deaths worldwide Young children and elderly or immunocompromised individuals are typically at greater risk of severe illness or death from influenza Newly emerging strains can result ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of Peptide Antibiotic Nucleic Acids
SBC: NUBAD LLC Topic: NIAIDDESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of iCrystal System for Rapid Crystallization of Biological Macromolecules
SBC: JUXTOPIA LLC Topic: 100DESCRIPTION provided by applicant Biological macromolecules are the machinery of life and understanding their function helps scientists to develop new drug treatments that target specific human diseases In this regard crystallization is routinely employed for the understanding of the molecular structures and the interactions of proteins with other biological and non biological materials Desp ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Biological treatment of bacterial keratitis
SBC: AMEBAGONE INC Topic: NDESCRIPTION provided by applicant Staphylococcus is the most common cause of infections worldwide The pathogen persists asymptomatically on human skin from which it may spread to ocular tissues and cause corneal infection When this happens corneal bacterial keratitis can occur and if not treated effectively it may lead to blindness Multi Drug Resistant MDR variants of S aureus Sa are ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Conformal Additive Cellular Heat Exchanger Technology (CACHET)
SBC: TECHNOLOGY ASSESSMENT AND TRANSFER, INC. Topic: N15AT019Technology Assessment & Transfer, Inc. and subcontractors propose novel, high performance additive manufactured (AM) heat exchangers for military systems. The AM process will allow for conformal, lightweight designs that optimize use of available space. Design and modeling efforts in Phase I will identify enhanced heat transfer surfaces compatible with, and made possible by, an AM fabrication appr ...
STTR Phase I 2015 Department of DefenseNavy -
High Performance and Novel Target Recognition Algorithm in the Sparse Measurement Space
SBC: Applied Research LLC Topic: AF15AT27ABSTRACT: Our main objective in this project is to propose a novel Structured Sparse Priors for Target Recognition (SSPTR) system and to demonstrate that discriminative applications such as data clustering or target detection, tracking, and classification can be solved effectively and directly on the compressed measurement domain without the need to recover the original data. Our proposed sparse-r ...
STTR Phase I 2015 Department of DefenseAir Force -
Development and testing of a behavioral activation mobile therapy for elevated depressive symptoms
SBC: MOUNTAINPASS TECHNOLOGY LLC Topic: 104DESCRIPTION provided by applicant Approximately of the population experiences elevated depressive symptoms Kubik et al Despite recent research suggesting that overall population mortality would be reduced by if the effects of subthreshold depression could be blocked completely the majority of individuals with elevated depressive symptoms never receive evidence based treat ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health